FDA Drug Recalls

1,018 recalls, newest first

Apr 13, 2022 Class II · Moderate risk

Epinephrine

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 04094-933-01 D-1098-2022

Apr 13, 2022 Class II · Moderate risk

Depo-Medrol

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0009-3475-01 D-1097-2022

Apr 13, 2022 Class II · Moderate risk

Depo-Medrol

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0009-3073-03 D-1096-2022

Apr 13, 2022 Class II · Moderate risk

Bupivacaine Hydrochloride

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0409-1163-01 D-1095-2022

Apr 13, 2022 Class II · Moderate risk

Labetalol Hydrochloride Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 49884-122-01 D-1094-2022

Apr 13, 2022 Class II · Moderate risk

Prazosin Hydrochloride Capsules

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0378-1101-01 D-1093-2022

Apr 13, 2022 Class II · Moderate risk

Loperamide Hydrochloride capsules

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0378-2100-01 D-1092-2022

Apr 13, 2022 Class II · Moderate risk

Duraclon (clonidine HCl injection, USP)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 67457-218-10 D-1091-2022

Apr 13, 2022 Class II · Moderate risk

Proventil HFA

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0085-1132-04 D-1090-2022

Apr 13, 2022 Class II · Moderate risk

Celestone Soluspan

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0085-4320-01 D-1089-2022

Apr 13, 2022 Class II · Moderate risk

Levofloxacin Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-6352-61 D-1088-2022

Apr 13, 2022 Class II · Moderate risk

Kinevac (Sincalide for Injection)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0270-0556-15 D-1087-2022

Apr 13, 2022 Class II · Moderate risk

Gastrografin

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0270-0445-35 D-1086-2022

Apr 13, 2022 Class II · Moderate risk

E-Z-Gas II

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0270-9020-01 D-1085-2022

Apr 13, 2022 Class II · Moderate risk

E-Z-HD (Barium Sulfate for Oral Suspension)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 32909-764-01 D-1084-2022

Apr 13, 2022 Class II · Moderate risk

Transderm Scop

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 10019-553-03 D-1083-2022

Apr 13, 2022 Class II · Moderate risk

Recothrom Thrombin Topical

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0338-0322-01 D-1082-2022

Apr 13, 2022 Class II · Moderate risk

Revonto (dantrolene sodium for injection)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 78670-003-67 D-1081-2022

Apr 13, 2022 Class II · Moderate risk

Revonto (dantrolene sodium for injection)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 27505-003-67 D-1080-2022

Apr 13, 2022 Class II · Moderate risk

Vecuronium Bromide for Injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0703-2914-03 D-1079-2022

Apr 13, 2022 Class II · Moderate risk

Propofol Injectable Emulsion

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0591-2136-95 D-1078-2022

Apr 13, 2022 Class II · Moderate risk

Propofol Injectable Emulsion

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 00591-2136-51 D-1077-2022

Apr 13, 2022 Class II · Moderate risk

Proair

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 59310-579-22 D-1076-2022

Apr 13, 2022 Class II · Moderate risk

Mupirocin Ointment

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0093-1010-42 D-1075-2022

Apr 13, 2022 Class II · Moderate risk

MethyLPREDNISolone Acetate Injectable Suspension USP

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0703-0063-01 D-1074-2022

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061